Good to Know > Arechar launches an effective formulation, Peg-Doxorubicin Liposomal

Arechar launches an effective formulation, Peg-Doxorubicin Liposomal

Arechar Healthcare announces the launch of PEGDOXINE, the most effective anticancer drug, comprising Doxorubicin Pegylated Liposomal to treat certain types of cancer ( for example ovarian cancer, AIDS-related Kaposi's sarcoma, breast cancer, multiple myeloma). Cancers' threat is growing with time all over the world. With this increasing incidence of cancer in the world, there's a need to create more and better solutions for the disease to control its command over the patients’ lives. To do so, Arechar Healthcare has launched this drug for the effective treatment of certain types of cancer. The manufacturing team of Arechar Healthcare has provided a brief description of Pegdoxine and its components.

  • PEGDOXINE is an antitumor antibiotic. It comprises Doxorubicin Pegylated. Often known as PLD (Pegylated Liposomal Doxorubicin), it is used in the treatment of certain types of cancer (ovarian cancer, AIDS-related Kaposi’s sarcoma, breast cancer), as prescribed by the doctor. Therefore, it is a prescription medicine.
  • Liposomal anthracyclines were developed because of the reason that Liposomal anthracyclines achieve lower cardiotoxicity by changing tissue distribution and by decreasing the rate of drug release.
  • The active ingredient of the PEGDOXINE is doxorubicin. PEGDOXINE is given as an injection into a vein by a professional healthcare provider.
  • The molecular formula of Doxorubicin C27H30ClNO11. Its molar mass is 543.52 g/mol. 

“Arechar Healthcare is committed to proving unmatchable competency and higher excellence in the field of healthcare, specifically in the oncology sector,” said Mr. Harpreet Singh, Founder of Arechar Healthcare. “With the launch of PEGDOXINE Doxorubicin Pegylated Liposomal, we have taken a step ahead to serve the best and the most affordable medicines to the patients, with utmost accessibility.”

“Our mission is not limited to manufacturing medicines, rather it focuses on the health of patients globally,” he added.

“With every little step towards achieving easy healthcare, we crave to manufacture the best and reliable life-saving drugs, for our mission is to make these medicines accessible to the patients in all the regions of the world,” said Mrs. Ruchika Rajbans, Co-Founder of Arechar Healthcare.

About Arechar Healthcare

Arechar Healthcare is one of the largest leading manufacturers of life-saving drugs, working to serve the patients with the best and approved life-saving drugs at an affordable range of prices. It has attained an authoritative position worldwide in the field of Pharma. It has successfully extended its reach globally and is working with immense insight into humanity. Very few manufacturers possess the drive and determination that the Arechar Healthcare Team has displayed, ever since it started. Focussing on the accessibility and efficacy of life-saving drugs, Arechar Healthcare aims to strengthen the healing and treatment process, with a major focus on oncology care and other diseases that threaten human lives.